Prevention of ambiguous genitalia by prenatal treatment with dexamethasone in pregnancies at risk for congenital adrenal hyperplasia

被引:2
|
作者
New, MI [1 ]
机构
[1] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY 10021 USA
关键词
D O I
10.1351/pac200375112013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Congenital adrenal hyperplasia (CAH) refers to a family of monogenic inherited disorders of adrenal steroidogenesis most often caused by a deficiency of the 21-hydroxylase enzyme. In the classic forms of CAH (simple virilizing and salt-wasting), androgen excess causes external genital ambiguity in newborn females and progressive postnatal virilization in males and females. Prenatal treatment of CAH with dexamethasone has been successfully utilized for over a decade. This article reports on 595 pregnancies prenatally diagnosed using amniocentesis or chorionic villus sampling between 1978 and 2002 at the New York Presbyterian Hospital-Weill Medical College of Cornell University. No significant or enduring side effects were noted in the fetuses, indicating that dexamethasone treatment is safe. Prenatally treated newborns did not differ in weight from untreated, unaffected newborns. Based on our experience, prenatal diagnosis and treatment of 21-hydroxylase deficiency is effective in significantly reducing or eliminating virilization in the newborn female. Prevention of genital virilization in female newborns with classic CAH avoids the risk of sex misassignment and diminishes the need for corrective surgery and the resulting psychological impact that may extend into adulthood.
引用
收藏
页码:2013 / 2022
页数:10
相关论文
共 50 条
  • [1] Prevention of Ambiguous genitalia in congenital adrenal hyperplasia
    AlHerbish, AS
    [J]. ANNALS OF SAUDI MEDICINE, 1996, 16 (03) : 320 - 322
  • [2] Congenital Adrenal Hyperplasia and Ambiguous Genitalia
    Sanfilippo, Joseph S.
    [J]. JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2011, 24 (05) : 235 - 235
  • [3] Ambiguous genitalia and hypertension in a patient with congenital adrenal hyperplasia
    Valsalan, R.
    Zimmermann, A.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 (03) : 334 - 337
  • [4] Outcome of prenatal dexamethasone treatment of congenital adrenal hyperplasia
    Ritzén, EM
    Lajic, S
    [J]. ENDOCRINOLOGIST, 2003, 13 (03): : 219 - 223
  • [5] Prenatal Dexamethasone for Congenital Adrenal Hyperplasia
    Dreger, Alice
    Feder, Ellen K.
    Tamar-Mattis, Anne
    [J]. JOURNAL OF BIOETHICAL INQUIRY, 2012, 9 (03) : 277 - 294
  • [6] Prevention of Virilization in Pregnancies at Risk of Congenital Adrenal Hyperplasia with Dexamethasone: A Systematic Review and Metaanalysis.
    Muthusamy, K.
    Fernandez-Balsells, M. M.
    Murad, H. M.
    Smushkin, G.
    Lampropulos, J. F.
    Elamin, M. B.
    Abu Elnour, N. O.
    Elamin, K. B.
    Agrwal, N.
    Gallegos-Orozco, J. F.
    Erwin, P. J.
    Montori, V. M.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03)
  • [7] Surgical aspects of ambiguous genitalia associated with congenital adrenal hyperplasia
    Lamoshi, Abdulraouf Y.
    El-Gharmooll, Bashir
    [J]. ANNALS OF PEDIATRIC SURGERY, 2015, 11 (04): : 226 - 230
  • [8] Congenital adrenal hyperplasia: outcomes surgical correction of ambiguous genitalia
    Uzhegova, Z.
    Andreeva, E.
    [J]. HUMAN REPRODUCTION, 2015, 30 : 447 - 447
  • [9] Prenatal Dexamethasone Treatment of Children at Risk for Congenital Adrenal Hyperplasia: The Swedish Experience and Standpoint
    Hirvikoski, Tatja
    Nordenstrom, Anna
    Wedell, Anna
    Ritzen, Martin
    Lajic, Svetlana
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (06): : 1881 - 1883
  • [10] Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia affects cognitive functions
    Hirvikoski, Tatja
    Nordenstrom, Anna
    Lindholm, Torun
    Wedell, Anna
    Ritzen, E. Martin
    Lajic, Svetlana
    [J]. HORMONE RESEARCH, 2006, 65 : 122 - 122